Free Trial

Mural Oncology (MURA) SEC Filings & 10K Form

Mural Oncology logo
$1.63 -0.05 (-2.98%)
As of 11:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Mural Oncology SEC Filings

DateFilerForm TypeView
08/04/2025
7:15 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025
7:04 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2025
4:00 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2025
4:00 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
4:00 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
4:00 PM
Loew Caroline (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2025
4:26 PM
Mural Oncology (Subject)
Prosight Management, LP (Filed by)
Form SCHEDULE 13G
06/13/2025
7:00 AM
Hickey Benjamin (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:00 AM
Golumbeski George (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:00 AM
Jackson Scott Thomas (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:00 AM
Minegishi Sachiyo (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:00 AM
Cuss Francis M (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:13 PM
FELDMAN STUART (Filed by)
Mural Oncology (Subject)
Form SCHEDULE 13G
04/28/2025
7:00 AM
Mural Oncology (Filer)
Form DEF 14A
04/28/2025
7:03 AM
Mural Oncology (Filer)
Form DEFA14A
04/28/2025
7:06 AM
Mural Oncology (Filer)
Form ARS
04/16/2025
4:37 PM
Mural Oncology (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SCHEDULE 13G
04/15/2025
7:06 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
5:38 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
3:56 PM
Mural Oncology (Filer)
Form 424B5
03/11/2025
3:58 PM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:10 PM
Loew Caroline (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:47 PM
Cutler Adam D. (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:47 PM
Goodman Vicki L (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:48 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:49 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
3:11 PM
Goodman Vicki L (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
11:18 AM
ACORN BIOVENTURES, L.P. (Filed by)
Mural Oncology (Subject)
Form SCHEDULE 13G/A
01/10/2025
6:00 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:19 PM
Keson-Brookes Maiken (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:06 PM
Loew Caroline (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
11:15 PM
Mural Oncology (Filer)
Form EFFECT
11/14/2024
2:18 PM
Mural Oncology (Subject)
Solas Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/13/2024
3:06 PM
Mural Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2024
6:04 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:05 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
2:52 PM
Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:39 PM
Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
6:04 AM
Cutler Adam D. (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:08 AM
Cutler Adam D. (Reporting)
Mural Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2024
6:30 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
09/23/2024
6:13 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:15 PM
ALTSCHULLER Susan (Reporting)
Mural Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:43 PM
ACORN BIOVENTURES, L.P. (Filed by)
Mural Oncology (Subject)
Form SCHEDULE 13G
08/13/2024
6:18 AM
Mural Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:19 AM
Mural Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MURA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners